Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer.
Saved in:
| Title: | Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer. |
|---|---|
| Authors: | William WN Jr (AUTHOR), Kies MS (AUTHOR), Fossella FV (AUTHOR), Liu DD (AUTHOR), Gladish G (AUTHOR), Tse WH (AUTHOR), Lee JJ (AUTHOR), Hong WK (AUTHOR), Lippman SM (AUTHOR), Kim ES (AUTHOR), William, William N Jr1 (AUTHOR), Kies, Merrill S (AUTHOR), Fossella, Frank V (AUTHOR), Liu, Diane D (AUTHOR), Gladish, Gregory (AUTHOR), Tse, Warner H (AUTHOR), Lee, J Jack (AUTHOR), Hong, Waun K (AUTHOR), Lippman, Scott M (AUTHOR), Kim, Edward S (AUTHOR) |
| Source: | Cancer (0008543X). 5/15/2010, Vol. 116 Issue 10, p2401-2408. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 0008543X |
|---|---|
| DOI: | 10.1002/cncr.24996 |
